Course Director:  Shane A. Bobart, MD

Primary Aldosteronism: The Evolving Landscape in Diagnosis, Management, and long-term Implications

Jawairia Shakil MD

Assistant Professor of Clinical Medicine

Houston Methodist Hospital

STATEMENT OF NEED
Primary Aldosteronism (PA) is a leading cause of secondary hypertension, yet it remains significantly underdiagnosed in clinical practice. With its strong association with cardiovascular and renal complications, particularly chronic kidney disease (CKD), there is an urgent need for healthcare providers to enhance their understanding of PA's evolving diagnostic and therapeutic landscape.
Recent advances in screening methods, genetic insights, and imaging techniques have improved the approach to diagnosing PA, allowing for more precise identification of subtypes and improved patient outcomes. 
This CME activity addresses these educational gaps by providing a comprehensive review of the latest advancements in PA diagnosis and management, with a focus on its implications for long term health outcomes. 

TARGET AUDIENCE
The target audience for this activity is: Physicians, Residents, Fellows, APPs.

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participant should be able to:

• Identify the pathophysiology, clinical manifestations, and subtypes of PA
• Apply updated diagnostic protocols, including imaging and adrenal vein sampling, for accurate detection of PA.
• Integrate current and emerging management strategies, both pharmacological and surgical, into clinical practice.
• Assess the impact of PA on long term health and develop individualized treatment plans to mitigate end organ complications.